Inhibikase Therapeutics - 53 Year Dividend History | IKT | MacroTrends

Delisted Stocks

Precious Metals

Inhibikase Therapeutics - 53 Year Dividend History | IKT

Historical dividend payout and yield for Inhibikase Therapeutics (IKT) since 1971. The current TTM dividend payout for Inhibikase Therapeutics (IKT) as of April 25, 2024 is $0.00. The current dividend yield for Inhibikase Therapeutics as of April 25, 2024 is 0.00%.

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$0.012B	$0.000B
Inhibikase Therapeutics Inc. is a clinical-stage pharmaceutical company. It engages in developing therapeutics for Parkinson's disease and related disorders. The company operates principally in Boston, Massachusetts. Inhibikase Therapeutics Inc. is headquartered in Atlanta, Georgia.

Stock Name	Country	Market Cap	PE Ratio

We Need Your Support!

Backlinks from other websites are the lifeblood of our site and a primary source of new traffic.

If you use our chart images on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. We have provided a few examples below that you can copy and paste to your site:

Link Preview	HTML Code (Click to Copy)
Inhibikase Therapeutics - 53 Year Dividend History \| IKT
Macrotrends
Source

Your image export is now complete. Please check your download folder.

We Need Your Support!

Backlinks from other websites are the lifeblood of our site and a primary source of new traffic.

If you use our datasets on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. We have provided a few examples below that you can copy and paste to your site:

Link Preview	HTML Code (Click to Copy)
Inhibikase Therapeutics - 53 Year Dividend History \| IKT
Macrotrends
Source

Your data export is now complete. Please check your download folder.